Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Multifaceted Roles of B Cells in Solid Tumors: Emerging Treatment Opportunities
Nicole Flynn, Rajasekharan Somasundaram, K. Arnold, et al.
Targeted Oncology (2017) Vol. 12, Iss. 2, pp. 139-152
Closed Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Immune crosstalk in cancer progression and metastatic spread: a complex conversation
Hannah Garner, Karin E. de Visser
Nature reviews. Immunology (2020) Vol. 20, Iss. 8, pp. 483-497
Closed Access | Times Cited: 326
Antitumor effects of immunity-enhancing traditional Chinese medicine
Yeshu Wang, Qunfang Zhang, Yuchao Chen, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 121, pp. 109570-109570
Open Access | Times Cited: 222
Defining HPV-specific B cell responses in patients with head and neck cancer
Andreas Wieland, Mihir R. Patel, Maria A. Cardenas, et al.
Nature (2020) Vol. 597, Iss. 7875, pp. 274-278
Open Access | Times Cited: 175
Atlas of breast cancer infiltrated B-lymphocytes revealed by paired single-cell RNA-sequencing and antigen receptor profiling
Qingtao Hu, Hong Yu, Qi Pan, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 155
Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses
Taghreed Hirz, Shenglin Mei, Hirak Sarkar, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 111
The Prognostic Importance of CD20+ B lymphocytes in Colorectal Cancer and the Relation to Other Immune Cell subsets
Sofia Edin, Tuomas Kaprio, Jaana Hagström, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 122
Obesity, Inflammation, and Prostate Cancer
Kazutoshi Fujita, Takuji Hayashi, Makoto Matsushita, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 2, pp. 201-201
Open Access | Times Cited: 120
Nanomedicines modulating tumor immunosuppressive cells to enhance cancer immunotherapy
Yuefei Zhu, Xiangrong Yu, Soracha Thamphiwatana, et al.
Acta Pharmaceutica Sinica B (2020) Vol. 10, Iss. 11, pp. 2054-2074
Open Access | Times Cited: 88
The Immune Microenvironment in Head and Neck Squamous Cell Carcinoma: on Subsets and Subsites
Niels E. Wondergem, Irene H. Nauta, Tara Muijlwijk, et al.
Current Oncology Reports (2020) Vol. 22, Iss. 8
Open Access | Times Cited: 73
Reigniting hope in cancer treatment: the promise and pitfalls of IL-2 and IL-2R targeting strategies
Shan Muhammad, Tao Fan, Yang Hai, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 42
Pharmacological inactivation of the PI3K p110δ prevents breast tumour progression by targeting cancer cells and macrophages
Evangelia Goulielmaki, Miriam Bermúdez-Brito, Margarita Andreou, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 6
Open Access | Times Cited: 43
Advances in Molecular Mechanisms for Traditional Chinese Medicine Actions in Regulating Tumor Immune Responses
Han Huang, Jiansong Fang, Xiude Fan, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 30
Zinc dampens antitumor immunity by promoting Foxp3+ regulatory T cells
Sugandha Narayan, Rajdeep Dalal, Zaigham Abbas Rizvi, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Cross-Talk Between Cancer and Its Cellular Environment—A Role in Cancer Progression
Eliza Turlej, Aleksandra Domaradzka, Justyna Radzka, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 403-403
Open Access
The tumor immune microenvironments of HPV+ and HPV− head and neck cancers
Steven F. Gameiro, Andris M. Evans, Joe S. Mymryk
WIREs Mechanisms of Disease (2021) Vol. 14, Iss. 2
Closed Access | Times Cited: 23
Clinical Trials of the BTK Inhibitors Ibrutinib and Acalabrutinib in Human Diseases Beyond B Cell Malignancies
Sining Zhu, Jaeyong Jung, Eton Victor, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 23
Tumor-B-cell interactions promote isotype switching to an immunosuppressive IgG4 antibody response through upregulation of IL-10 in triple negative breast cancers
Nicole J. Toney, Lynn M. Opdenaker, Kader Cicek, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 16
The influence of chemotherapy on adenosine-producing B cells in patients with head and neck squamous cell carcinoma
Andreas Ziebart, U Huber, S Jeske, et al.
Oncotarget (2017) Vol. 9, Iss. 5, pp. 5834-5847
Open Access | Times Cited: 22
The significance of cytokine-producing B cells in breast tumor-draining lymph nodes
Fereshteh Mehdipour, Mahboobeh Razmkhah, Zahra Faghih, et al.
Cellular Oncology (2019) Vol. 42, Iss. 3, pp. 381-395
Closed Access | Times Cited: 22
Atypical memory B cells increase in the peripheral blood of patients with breast cancer regardless of lymph node involvement
Atefeh Azizi, Fereshteh Mehdipour, Morteza Samadi, et al.
BMC Immunology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2
B cells and antibody production in melanoma
Jessica Da Gama Duarte, Janique M. Peyper, Jonathan M. Blackburn
Mammalian Genome (2018) Vol. 29, Iss. 11-12, pp. 790-805
Closed Access | Times Cited: 20
Deceleration of glycometabolism impedes IgG‐producing B‐cell‐mediated tumor elimination by targeting SATB1
Jiajing Liu, Yifan Li, Lu Zhou, et al.
Immunology (2018) Vol. 156, Iss. 1, pp. 56-68
Open Access | Times Cited: 19
Sequential modulation of the Wnt/β-catenin signaling pathway enhances tumor-intrinsic MHC I expression and tumor clearance
Jhalak Dholakia, Carly Bess Scalise, Ashwini A. Katre, et al.
Gynecologic Oncology (2021) Vol. 164, Iss. 1, pp. 170-180
Open Access | Times Cited: 14
Tumor-Infiltrating Immune Cells and HLA Expression as Potential Biomarkers Predicting Response to PD-1 Inhibitor Therapy in Stage IV Melanoma Patients
Barbara Hegyi, Kristóf György Csikó, Tímea Balatoni, et al.
Biomolecules (2024) Vol. 14, Iss. 12, pp. 1609-1609
Open Access | Times Cited: 1
The Immunomodulatory Role of Hypoxic Tumor-Derived Extracellular Vesicles
Joël E.J. Beaumont, Nicky A. Beelen, Lotte Wieten, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 4001-4001
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top